BioCentury | Oct 31, 2017
Politics & Policy

Connecticut AG expands generics lawsuit

..."both intend to defend this case vigorously." Other defendants named in the new complaint include Lannett Co. Inc....
...The suit was filed in the U.S. District Court for the Eastern District of Pennsylvania. Lannett...
BioCentury | Sep 7, 2015
Company News

Lannett, UCB neurology, generics news

...UCB is selling its U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett for $1.2 billion...
...& Johnson (NYSE:JNJ, New Brunswick, N.J.). The parties expect the deal to close in 4Q15. Lannett Co. Inc....
BioCentury | Sep 4, 2015
Company News

UCB sells U.S. generics unit to Lannett

...UCB Group (Euronext:UCB) is selling U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett Co. Inc. (NYSE:LCI) for...
BioCentury | Dec 15, 2014
Company News

Lannett management update

Lannett Co. Inc. (NYSE:LCI), Philadelphia, Pa. Business: Generics Hired: Michael Bogda as president, formerly EVP of Americas technical operations at Teva Pharmaceutical Industries Ltd. ; he succeeds Arthur Bedrosian, who remains CEO WIR Staff...
BioCentury | Nov 26, 2014
Politics & Policy

Lawmakers propose Medicaid rebates for generic price hikes

...competition to increase access and reduce costs. The CEOs of Marathon Pharmaceuticals LLC (Northbrook, Ill.), Lannett Co. Inc....
...generic prices last month. The legislators sent letters to 14 generic drug manufacturers, including Marathon, Lannett...
BioCentury | Aug 11, 2014
Company News

Symplmed, Lannett deal

...Symplmed granted Lannett exclusive rights to distribute an authorized generic of 2, 4 and 8 mg...
...an authorized generic of 2, 4 and 8 mg Aceon perindopril erbumine in the U.S. Lannett...
...see BioCentury, Feb. 6, 2012 & July 15, 2013). Symplmed Pharmaceuticals LLC , Cincinnati, Ohio Lannett Co. Inc....
BioCentury | Jan 9, 2012
Finance

PDUFAs produce yawns

Stephen Hansen Senior Writer There are more than twice as many PDUFA dates this year than last - at least 40 vs. 17 - but only a handful of potential approvals are drumming up interest among buysiders....
BioCentury | Jan 9, 2012
Clinical News

C-Topical: SPA received

...reference data on safety and efficacy from the scientific literature or from previously approved products. Lannett Co. Inc....
BioCentury | Apr 11, 2011
Company News

Celgene, Lannett cancer, generics news

...to dismiss a case brought by generics company Lannett seeking to require Celgene to provide Lannett...
...to dismiss a case brought by generics company Lannett seeking to require Celgene to provide Lannett...
...motion was denied because Lannett had not yet received an FDA response for the studies. Lannett...
BioCentury | Jun 24, 2004
Company News

FDA denies Abbott's Synthroid petition

...secondary, tertiary and subclinical hypothyroidism. Indeed, FDA also approved generic levothyroxine from Mylan (MYL) and Lannett...
Items per page:
1 - 10 of 10
BioCentury | Oct 31, 2017
Politics & Policy

Connecticut AG expands generics lawsuit

..."both intend to defend this case vigorously." Other defendants named in the new complaint include Lannett Co. Inc....
...The suit was filed in the U.S. District Court for the Eastern District of Pennsylvania. Lannett...
BioCentury | Sep 7, 2015
Company News

Lannett, UCB neurology, generics news

...UCB is selling its U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett for $1.2 billion...
...& Johnson (NYSE:JNJ, New Brunswick, N.J.). The parties expect the deal to close in 4Q15. Lannett Co. Inc....
BioCentury | Sep 4, 2015
Company News

UCB sells U.S. generics unit to Lannett

...UCB Group (Euronext:UCB) is selling U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett Co. Inc. (NYSE:LCI) for...
BioCentury | Dec 15, 2014
Company News

Lannett management update

Lannett Co. Inc. (NYSE:LCI), Philadelphia, Pa. Business: Generics Hired: Michael Bogda as president, formerly EVP of Americas technical operations at Teva Pharmaceutical Industries Ltd. ; he succeeds Arthur Bedrosian, who remains CEO WIR Staff...
BioCentury | Nov 26, 2014
Politics & Policy

Lawmakers propose Medicaid rebates for generic price hikes

...competition to increase access and reduce costs. The CEOs of Marathon Pharmaceuticals LLC (Northbrook, Ill.), Lannett Co. Inc....
...generic prices last month. The legislators sent letters to 14 generic drug manufacturers, including Marathon, Lannett...
BioCentury | Aug 11, 2014
Company News

Symplmed, Lannett deal

...Symplmed granted Lannett exclusive rights to distribute an authorized generic of 2, 4 and 8 mg...
...an authorized generic of 2, 4 and 8 mg Aceon perindopril erbumine in the U.S. Lannett...
...see BioCentury, Feb. 6, 2012 & July 15, 2013). Symplmed Pharmaceuticals LLC , Cincinnati, Ohio Lannett Co. Inc....
BioCentury | Jan 9, 2012
Finance

PDUFAs produce yawns

Stephen Hansen Senior Writer There are more than twice as many PDUFA dates this year than last - at least 40 vs. 17 - but only a handful of potential approvals are drumming up interest among buysiders....
BioCentury | Jan 9, 2012
Clinical News

C-Topical: SPA received

...reference data on safety and efficacy from the scientific literature or from previously approved products. Lannett Co. Inc....
BioCentury | Apr 11, 2011
Company News

Celgene, Lannett cancer, generics news

...to dismiss a case brought by generics company Lannett seeking to require Celgene to provide Lannett...
...to dismiss a case brought by generics company Lannett seeking to require Celgene to provide Lannett...
...motion was denied because Lannett had not yet received an FDA response for the studies. Lannett...
BioCentury | Jun 24, 2004
Company News

FDA denies Abbott's Synthroid petition

...secondary, tertiary and subclinical hypothyroidism. Indeed, FDA also approved generic levothyroxine from Mylan (MYL) and Lannett...
Items per page:
1 - 10 of 10